154 related articles for article (PubMed ID: 10869414)
1. Activity-dependent neurotrophic factor: intranasal administration of femtomolar-acting peptides improve performance in a water maze.
Gozes I; Giladi E; Pinhasov A; Bardea A; Brenneman DE
J Pharmacol Exp Ther; 2000 Jun; 293(3):1091-8. PubMed ID: 10869414
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective effect of the peptides ADNF-9 and NAP on hypoxic-ischemic brain injury in neonatal rats.
Kumral A; Yesilirmak DC; Sonmez U; Baskin H; Tugyan K; Yilmaz O; Genc S; Gokmen N; Genc K; Duman N; Ozkan H
Brain Res; 2006 Oct; 1115(1):169-78. PubMed ID: 16938277
[TBL] [Abstract][Full Text] [Related]
3. NAP and ADNF-9 protect normal and Down's syndrome cortical neurons from oxidative damage and apoptosis.
Busciglio J; Pelsman A; Helguera P; Ashur-Fabian O; Pinhasov A; Brenneman DE; Gozes I
Curr Pharm Des; 2007; 13(11):1091-8. PubMed ID: 17430172
[TBL] [Abstract][Full Text] [Related]
4. Antiserum to activity-dependent neurotrophic factor produces neuronal cell death in CNS cultures: immunological and biological specificity.
Gozes I; Davidson A; Gozes Y; Mascolo R; Barth R; Warren D; Hauser J; Brenneman DE
Brain Res Dev Brain Res; 1997 Apr; 99(2):167-75. PubMed ID: 9125470
[TBL] [Abstract][Full Text] [Related]
5. Intranasal administration of NAP, a neuroprotective peptide, decreases anxiety-like behavior in aging mice in the elevated plus maze.
Alcalay RN; Giladi E; Pick CG; Gozes I
Neurosci Lett; 2004 May; 361(1-3):128-31. PubMed ID: 15135910
[TBL] [Abstract][Full Text] [Related]
6. Activity-dependent neurotrophic factor: structure-activity relationships of femtomolar-acting peptides.
Brenneman DE; Hauser J; Neale E; Rubinraut S; Fridkin M; Davidson A; Gozes I
J Pharmacol Exp Ther; 1998 May; 285(2):619-27. PubMed ID: 9580606
[TBL] [Abstract][Full Text] [Related]
7. NAP accelerates the performance of normal rats in the water maze.
Gozes I; Alcalay R; Giladi E; Pinhasov A; Furman S; Brenneman DE
J Mol Neurosci; 2002; 19(1-2):167-70. PubMed ID: 12212775
[TBL] [Abstract][Full Text] [Related]
8. NAP and D-SAL: neuroprotection against the beta amyloid peptide (1-42).
Gozes I; Divinski I; Piltzer I
BMC Neurosci; 2008 Dec; 9 Suppl 3(Suppl 3):S3. PubMed ID: 19091000
[TBL] [Abstract][Full Text] [Related]
9. Activity-dependent neurotrophic factor-9 and NAP promote neurite outgrowth in rat hippocampal and cortical cultures.
Smith-Swintosky VL; Gozes I; Brenneman DE; D'Andrea MR; Plata-Salaman CR
J Mol Neurosci; 2005; 25(3):225-38. PubMed ID: 15800376
[TBL] [Abstract][Full Text] [Related]
10. VIP and peptides related to activity-dependent neurotrophic factor protect PC12 cells against oxidative stress.
Steingart RA; Solomon B; Brenneman DE; Fridkin M; Gozes I
J Mol Neurosci; 2000 Dec; 15(3):137-45. PubMed ID: 11303778
[TBL] [Abstract][Full Text] [Related]
11. D-SAL and NAP: Two Peptides Sharing a SIP Domain.
Gozes I; Sragovich S; Schirer Y; Idan-Feldman A
J Mol Neurosci; 2016 Jun; 59(2):220-31. PubMed ID: 26816081
[TBL] [Abstract][Full Text] [Related]
12. The peptides ADNF-9 and NAP increase survival and neurite outgrowth of rat retinal ganglion cells in vitro.
Lagrèze WA; Pielen A; Steingart R; Schlunck G; Hofmann HD; Gozes I; Kirsch M
Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):933-8. PubMed ID: 15728550
[TBL] [Abstract][Full Text] [Related]
13. A new concept in the pharmacology of neuroprotection.
Gozes I; Brenneman DE
J Mol Neurosci; 2000; 14(1-2):61-8. PubMed ID: 10854037
[TBL] [Abstract][Full Text] [Related]
14. Neurotrophic peptides, ADNF-9 and NAP, prevent alcohol-induced apoptosis at midgestation in fetal brains of C57BL/6 mouse.
Sari Y; Weedman JM; Nkrumah-Abrokwah M
J Mol Neurosci; 2013 Jan; 49(1):150-6. PubMed ID: 23229836
[TBL] [Abstract][Full Text] [Related]
15. A femtomolar-acting neuroprotective peptide induces increased levels of heat shock protein 60 in rat cortical neurons: a potential neuroprotective mechanism.
Zamostiano R; Pinhasov A; Bassan M; Perl O; Steingart RA; Atlas R; Brenneman DE; Gozes I
Neurosci Lett; 1999 Apr; 264(1-3):9-12. PubMed ID: 10320001
[TBL] [Abstract][Full Text] [Related]
16. Protection against tauopathy by the drug candidates NAP (davunetide) and D-SAL: biochemical, cellular and behavioral aspects.
Shiryaev N; Pikman R; Giladi E; Gozes I
Curr Pharm Des; 2011; 17(25):2603-12. PubMed ID: 21728979
[TBL] [Abstract][Full Text] [Related]
17. Activity-dependent neurotrophic factor-14 requires protein kinase C and mitogen-associated protein kinase kinase activation to protect the developing mouse brain against excitotoxicity.
Gressens P; Marret S; Bodénant C; Schwendimann L; Evrard P
J Mol Neurosci; 1999; 13(1-2):199-210. PubMed ID: 10691306
[TBL] [Abstract][Full Text] [Related]
18. Lactoferrin-modified PEG-co-PCL nanoparticles for enhanced brain delivery of NAP peptide following intranasal administration.
Liu Z; Jiang M; Kang T; Miao D; Gu G; Song Q; Yao L; Hu Q; Tu Y; Pang Z; Chen H; Jiang X; Gao X; Chen J
Biomaterials; 2013 May; 34(15):3870-81. PubMed ID: 23453061
[TBL] [Abstract][Full Text] [Related]
19. Complete sequence of a novel protein containing a femtomolar-activity-dependent neuroprotective peptide.
Bassan M; Zamostiano R; Davidson A; Pinhasov A; Giladi E; Perl O; Bassan H; Blat C; Gibney G; Glazner G; Brenneman DE; Gozes I
J Neurochem; 1999 Mar; 72(3):1283-93. PubMed ID: 10037502
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of nose-to-brain delivery of basic fibroblast growth factor for improving rat memory impairments induced by co-injection of β-amyloid and ibotenic acid into the bilateral hippocampus.
Feng C; Zhang C; Shao X; Liu Q; Qian Y; Feng L; Chen J; Zha Y; Zhang Q; Jiang X
Int J Pharm; 2012 Feb; 423(2):226-34. PubMed ID: 22193058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
